Shocking raise. To me it’s taking advantage of those holders who currently have liquidity issues under the positive guise of using the existing shareholder base over sophisticated shareholders. Current holders who have supported the price in the 5’s and 6’s and are now getting taken to the cleaners. Not impressed one bit.
- Forums
- ASX - By Stock
- VYS
- News: VYS Vysarn Expects Full Year EBITDA To 30 June Will Be About $5.90M
News: VYS Vysarn Expects Full Year EBITDA To 30 June Will Be About $5.90M, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add VYS (ASX) to my watchlist
|
|||||
Last
32.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $133.9M |
Open | High | Low | Value | Volume |
32.0¢ | 32.5¢ | 32.0¢ | $28.93K | 90.35K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1290 | 32.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
32.5¢ | 48739 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 21261 | 0.315 |
5 | 184000 | 0.310 |
2 | 13114 | 0.305 |
1 | 35000 | 0.300 |
2 | 107389 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.325 | 48739 | 1 |
0.330 | 100000 | 1 |
0.335 | 13548 | 1 |
0.340 | 122239 | 6 |
0.345 | 100000 | 1 |
Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
Featured News
RNU
Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
TLX
Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
VYS (ASX) Chart |